Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Plasma levels of mannose-binding lectin and future risk of venous thromboembolism

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Reply to: Clinical impact of high platelet count and high hematocrit, by Marc Sorigue

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Towards patient-specific management of trauma hemorrhage: the effect of resuscitation therapy on parameters of thromboelastometry

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Recommendations on thromboprophylaxis in major joint arthroplasty - many guidelines, little consensus?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Fatal pneumococcus meningitis in a child with complement factor ficolin-3 deficiency

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. Proteomics-Based Comparative Mapping of the Secretomes of Human Brown and White Adipocytes Reveals EPDR1 as a Novel Batokine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The impact of mannose-binding lectin polymorphisms on lung function in primary ciliary dyskinesia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Robin A Liang
  • Ina I Høiland
  • Thor Ueland
  • Pål Aukrust
  • Omri Snir
  • Kristian Hindberg
  • Sigrid K Braekkan
  • Peter Garred
  • Tom E Mollnes
  • John-Bjarne Hansen
Vis graf over relationer

BACKGROUND: Animal and observational studies have suggested a pathophysiological role for complement in venous thromboembolism (VTE), but the initiating mechanisms are unknown. Mannose-binding lectin (MBL) bound to altered host cells leads to activation of the lectin complement pathway, and both high and low MBL levels have been implicated in the pathophysiology of cardiovascular disease.

OBJECTIVES: To investigate the association between plasma MBL levels and future risk of incident VTE.

METHODS: We conducted a nested case-control study in 417 VTE patients and 849 age-matched and sex-matched controls derived from the general population (Tromsø Study). Plasma MBL levels were measured using enzyme-linked immunosorbent assay. Logistic regression models were used to estimate odds ratio (OR) for VTE across quartiles of plasma MBL levels.

RESULTS: Subjects with plasma MBL levels in the lowest quartile (<435 ng/mL) had a reduced OR for overall VTE (OR 0.79, 95% confidence interval [CI]: 0.56-1.10) and for DVT (OR 0.70, 95% CI: 0.47-1.04) compared to those with MBL in the highest quartile (≥2423 ng/mL) after multivariable adjustments. For VTE, DVT, and pulmonary embolism (PE) the ORs decreased substantially with decreasing time between blood sampling and VTE event.

CONCLUSIONS: Our findings suggest that low plasma MBL levels are associated with reduced risk of VTE, and DVT in particular.

TidsskriftJournal of thrombosis and haemostasis : JTH
Sider (fra-til)1661-1669
Antal sider9
StatusUdgivet - 20 jun. 2019

Bibliografisk note

© 2019 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals, Inc. on behalf of International Society on Thrombosis and Haemostasis.

ID: 58007864